APO RESEARCH · REPORT
Recombinant Proteins
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Product & engineering
Understand the product.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Selected research
Market Structure
Global Recombinant Proteins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018.
Top 5 companies occupied 40% of the market.
Read the full market overview
By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.
Report Includes
This report provides an overview of the global Recombinant Proteins market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Recombinant Proteins and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Recombinant Proteins revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Recombinant Proteins market size, projected growth trends, production technologies, key applications, and end-use industries.
Recombinant Proteins Segment by Company
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Recombinant Proteins Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Recombinant Proteins Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Proteins Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Proteins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Recombinant Proteins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Proteins industry.
Chapter 3: Detailed analysis of Recombinant Proteins companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Proteinsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hormones
- Growth Factors
- Cytokines
- Plasma Protein Factor
- Recombinant Metabolic Enzymes
- Immune Checkpoint Regulators
- Others
Applications
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
Companies covered
- Abcam PLC
- R&D Systems
- Miltenyi Biotec
- Thermo Fisher Scientific
- Sigma Aldrich Company
- GE Healthcare
- Lonza
- Merck KGaA
- ProSpec Tany TechnoGene
- Eurogentec (Kaneka Corporation)
- PeproTech
- BPS Bioscience
- Reprocell
- GenScript Biotech Corporation
- Abnova Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Hormones
- 1.2.3 Growth Factors
- 1.2.4 Cytokines
- 1.2.5 Plasma Protein Factor
- 1.2.6 Recombinant Metabolic Enzymes
- 1.2.7 Immune Checkpoint Regulators
- 1.2.8 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical Companies
- 1.3.3 Academic and Research Institutes
- 1.3.4 Contract Research Organizations
- 1.4 Global Market Growth Prospects
- 1.5 Global Recombinant Proteins Growth Trends by Region
- 1.5.1 Global Recombinant Proteins Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Recombinant Proteins Market Size by Region (2021-2026)
- 1.5.3 Recombinant Proteins Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Recombinant Proteins Market Dynamics
- 2.1 Recombinant Proteins Industry Trends
- 2.2 Recombinant Proteins Industry Drivers
- 2.3 Recombinant Proteins Industry Opportunities and Challenges
- 2.4 Recombinant Proteins Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Recombinant Proteins Revenue by Company (2021-2026)
- 3.2 Global Recombinant Proteins Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Recombinant Proteins Key Company Head office and Area Served
- 3.4 Global Recombinant Proteins Company, Product Type & Application
- 3.5 Global Recombinant Proteins Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Recombinant Proteins Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Recombinant Proteins Players Market Share by Revenue in 2025
- 3.6.3 2025 Recombinant Proteins Tier 1, Tier 2, and Tier 3
4 Recombinant Proteins Market by Type
- 4.1 Global Recombinant Proteins Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Recombinant Proteins Market Size by Type (2021-2032)
- 4.3 Global Recombinant Proteins Market Size Share by Type (2021-2032)
5 Recombinant Proteins Market by Application
- 5.1 Global Recombinant Proteins Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Recombinant Proteins Market Size by Application (2021-2032)
- 5.3 Global Recombinant Proteins Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abcam PLC
- 6.1.1 Abcam PLC Company Information
- 6.1.2 Abcam PLC Business Overview
- 6.1.3 Abcam PLC Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abcam PLC Recombinant Proteins Product Portfolio
- 6.1.5 Abcam PLC Recent Developments
- 6.2 R&D Systems
- 6.2.1 R&D Systems Company Information
- 6.2.2 R&D Systems Business Overview
- 6.2.3 R&D Systems Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 R&D Systems Recombinant Proteins Product Portfolio
- 6.2.5 R&D Systems Recent Developments
- 6.3 Miltenyi Biotec
- 6.3.1 Miltenyi Biotec Company Information
- 6.3.2 Miltenyi Biotec Business Overview
- 6.3.3 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Miltenyi Biotec Recombinant Proteins Product Portfolio
- 6.3.5 Miltenyi Biotec Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Thermo Fisher Scientific Recombinant Proteins Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 Sigma Aldrich Company
- 6.5.1 Sigma Aldrich Company Company Information
- 6.5.2 Sigma Aldrich Company Business Overview
- 6.5.3 Sigma Aldrich Company Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sigma Aldrich Company Recombinant Proteins Product Portfolio
- 6.5.5 Sigma Aldrich Company Recent Developments
- 6.6 GE Healthcare
- 6.6.1 GE Healthcare Company Information
- 6.6.2 GE Healthcare Business Overview
- 6.6.3 GE Healthcare Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GE Healthcare Recombinant Proteins Product Portfolio
- 6.6.5 GE Healthcare Recent Developments
- 6.7 Lonza
- 6.7.1 Lonza Company Information
- 6.7.2 Lonza Business Overview
- 6.7.3 Lonza Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Lonza Recombinant Proteins Product Portfolio
- 6.7.5 Lonza Recent Developments
- 6.8 Merck KGaA
- 6.8.1 Merck KGaA Company Information
- 6.8.2 Merck KGaA Business Overview
- 6.8.3 Merck KGaA Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Merck KGaA Recombinant Proteins Product Portfolio
- 6.8.5 Merck KGaA Recent Developments
- 6.9 ProSpec Tany TechnoGene
- 6.9.1 ProSpec Tany TechnoGene Company Information
- 6.9.2 ProSpec Tany TechnoGene Business Overview
- 6.9.3 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ProSpec Tany TechnoGene Recombinant Proteins Product Portfolio
- 6.9.5 ProSpec Tany TechnoGene Recent Developments
- 6.10 Eurogentec (Kaneka Corporation)
- 6.10.1 Eurogentec (Kaneka Corporation) Company Information
- 6.10.2 Eurogentec (Kaneka Corporation) Business Overview
- 6.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Product Portfolio
- 6.10.5 Eurogentec (Kaneka Corporation) Recent Developments
- 6.11 PeproTech
- 6.11.1 PeproTech Company Information
- 6.11.2 PeproTech Business Overview
- 6.11.3 PeproTech Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 PeproTech Recombinant Proteins Product Portfolio
- 6.11.5 PeproTech Recent Developments
- 6.12 BPS Bioscience
- 6.12.1 BPS Bioscience Company Information
- 6.12.2 BPS Bioscience Business Overview
- 6.12.3 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 BPS Bioscience Recombinant Proteins Product Portfolio
- 6.12.5 BPS Bioscience Recent Developments
- 6.13 Reprocell
- 6.13.1 Reprocell Company Information
- 6.13.2 Reprocell Business Overview
- 6.13.3 Reprocell Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Reprocell Recombinant Proteins Product Portfolio
- 6.13.5 Reprocell Recent Developments
- 6.14 GenScript Biotech Corporation
- 6.14.1 GenScript Biotech Corporation Company Information
- 6.14.2 GenScript Biotech Corporation Business Overview
- 6.14.3 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 GenScript Biotech Corporation Recombinant Proteins Product Portfolio
- 6.14.5 GenScript Biotech Corporation Recent Developments
- 6.15 Abnova Corporation
- 6.15.1 Abnova Corporation Company Information
- 6.15.2 Abnova Corporation Business Overview
- 6.15.3 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Abnova Corporation Recombinant Proteins Product Portfolio
- 6.15.5 Abnova Corporation Recent Developments
7 North America
- 7.1 North America Recombinant Proteins Market Size (2021-2032)
- 7.2 North America Recombinant Proteins Market Size by Type
- 7.2.1 North America Recombinant Proteins Market Size by Type (2021-2026)
- 7.2.2 North America Recombinant Proteins Market Size by Type (2027-2032)
- 7.2.3 North America Recombinant Proteins Market Share by Type (2021-2032)
- 7.3 North America Recombinant Proteins Market Size by Application
- 7.3.1 North America Recombinant Proteins Market Size by Application (2021-2026)
- 7.3.2 North America Recombinant Proteins Market Size by Application (2027-2032)
- 7.3.3 North America Recombinant Proteins Market Share by Application (2021-2032)
- 7.4 North America Recombinant Proteins Market Size by Country
- 7.4.1 North America Recombinant Proteins Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Recombinant Proteins Market Size by Country (2021-2026)
- 7.4.3 North America Recombinant Proteins Market Size by Country (2027-2032)
- 7.4.4 North America Recombinant Proteins Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Recombinant Proteins Market Size (2021-2032)
- 8.2 Europe Recombinant Proteins Market Size by Type
- 8.2.1 Europe Recombinant Proteins Market Size by Type (2021-2026)
- 8.2.2 Europe Recombinant Proteins Market Size by Type (2027-2032)
- 8.2.3 Europe Recombinant Proteins Market Share by Type (2021-2032)
- 8.3 Europe Recombinant Proteins Market Size by Application
- 8.3.1 Europe Recombinant Proteins Market Size by Application (2021-2026)
- 8.3.2 Europe Recombinant Proteins Market Size by Application (2027-2032)
- 8.3.3 Europe Recombinant Proteins Market Share by Application (2021-2032)
- 8.4 Europe Recombinant Proteins Market Size by Country
- 8.4.1 Europe Recombinant Proteins Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Recombinant Proteins Market Size by Country (2021-2026)
- 8.4.3 Europe Recombinant Proteins Market Size by Country (2027-2032)
- 8.4.4 Europe Recombinant Proteins Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Recombinant Proteins Market Size (2021-2032)
- 9.2 China Recombinant Proteins Market Size by Type
- 9.2.1 China Recombinant Proteins Market Size by Type (2021-2026)
- 9.2.2 China Recombinant Proteins Market Size by Type (2027-2032)
- 9.2.3 China Recombinant Proteins Market Share by Type (2021-2032)
- 9.3 China Recombinant Proteins Market Size by Application
- 9.3.1 China Recombinant Proteins Market Size by Application (2021-2026)
- 9.3.2 China Recombinant Proteins Market Size by Application (2027-2032)
- 9.3.3 China Recombinant Proteins Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Recombinant Proteins Market Size (2021-2032)
- 10.2 Asia Recombinant Proteins Market Size by Type
- 10.2.1 Asia Recombinant Proteins Market Size by Type (2021-2026)
- 10.2.2 Asia Recombinant Proteins Market Size by Type (2027-2032)
- 10.2.3 Asia Recombinant Proteins Market Share by Type (2021-2032)
- 10.3 Asia Recombinant Proteins Market Size by Application
- 10.3.1 Asia Recombinant Proteins Market Size by Application (2021-2026)
- 10.3.2 Asia Recombinant Proteins Market Size by Application (2027-2032)
- 10.3.3 Asia Recombinant Proteins Market Share by Application (2021-2032)
- 10.4 Asia Recombinant Proteins Market Size by Country
- 10.4.1 Asia Recombinant Proteins Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Recombinant Proteins Market Size by Country (2021-2026)
- 10.4.3 Asia Recombinant Proteins Market Size by Country (2027-2032)
- 10.4.4 Asia Recombinant Proteins Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Recombinant Proteins Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Recombinant Proteins Market Size by Type
- 11.2.1 South America, Middle East & Africa Recombinant Proteins Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Recombinant Proteins Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Recombinant Proteins Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Recombinant Proteins Market Size by Application
- 11.3.1 South America, Middle East & Africa Recombinant Proteins Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Recombinant Proteins Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Recombinant Proteins Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Recombinant Proteins Market Size by Country
- 11.4.1 South America, Middle East & Africa Recombinant Proteins Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Recombinant Proteins Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Recombinant Proteins Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Recombinant Proteins Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst